A potential contribution of antimicrobial peptide LL-37 to tissue fibrosis and vasculopathy in systemic sclerosis

Decrease of LL-37 in systemic sclerosis: a new marker for interstitial lung disease?

(2015) Mutlu Hizal et al.   CLINICAL RHEUMATOLOGY

A possible contribution of endothelial CCN1 downregulation due to Fli1 deficiency to the development of digital ulcers in systemic sclerosis

(2015) Ryosuke Saigusa et al.   EXPERIMENTAL DERMATOLOGY

Epigenetic suppression of Fli1, a potential predisposing factor in the pathogenesis of systemic sclerosis

(2015) Yoshihide Asano   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

Multifaceted contribution of the TLR4-activated IRF5 transcription factor in systemic sclerosis

(2015) Ryosuke Saigusa et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Fibrosis, Vascular Activation, and Immune Abnormalities Resembling Systemic Sclerosis in Bleomycin-Treated Fli-1-Haploinsufficient Mice

(2015) Takashi Taniguchi et al.   Arthritis & Rheumatology

Dynamics of serum angiopoietin-2 levels correlate with efficacy of intravenous pulse cyclophosphamide therapy for interstitial lung disease associated with systemic sclerosis

(2014) Takehiro Takahashi et al.   Modern Rheumatology

Increased expression of chemerin in endothelial cells due to Fli1 deficiency may contribute to the development of digital ulcers in systemic sclerosis

(2014) Kaname Akamata et al.   RHEUMATOLOGY

Bosentan reverses the pro-fibrotic phenotype of systemic sclerosis dermal fibroblasts via increasing DNA binding ability of transcription factor Fli1

(2014) Kaname Akamata et al.   ARTHRITIS RESEARCH & THERAPY

Simultaneous downregulation of KLF5 and Fli1 is a key feature underlying systemic sclerosis

(2014) Shinji Noda et al.   Nature Communications

Amelioration of Tissue Fibrosis by Toll-like Receptor 4 Knockout in Murine Models of Systemic Sclerosis

(2014) Takehiro Takahashi et al.   Arthritis & Rheumatology

2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative

(2013) Frank van den Hoogen et al.   ANNALS OF THE RHEUMATIC DISEASES

Fli1 deficiency contributes to the suppression of endothelial CXCL5 expression in systemic sclerosis

(2013) Yohei Ichimura et al.   ARCHIVES OF DERMATOLOGICAL RESEARCH

Little Peptide, Big Effects: The Role of LL-37 in Inflammation and Autoimmune Disease

(2013) J. M. Kahlenberg et al.   JOURNAL OF IMMUNOLOGY

Decreased cathepsin V expression due to Fli1 deficiency contributes to the development of dermal fibrosis and proliferative vasculopathy in systemic sclerosis

(2013) S. Noda et al.   RHEUMATOLOGY

Clinical significance of serum soluble Tie1 levels in patients with systemic sclerosis

(2012) Shinji Noda et al.   ARCHIVES OF DERMATOLOGICAL RESEARCH

A Possible Contribution of Altered Cathepsin B Expression to the Development of Skin Sclerosis and Vasculopathy in Systemic Sclerosis

(2012) Shinji Noda et al.   PLoS One

Effects of bosentan on nondigital ulcers in patients with systemic sclerosis

(2011) T. Taniguchi et al.   BRITISH JOURNAL OF DERMATOLOGY

LL-37 suppresses sodium nitroprusside-induced apoptosis of systemic sclerosis dermal fibroblasts

(2011) Hee Jung Kim et al.   EXPERIMENTAL DERMATOLOGY

Human anti-microbial cathelicidin peptide LL-37 suppresses the LPS-induced apoptosis of endothelial cells

(2011) Kaori Suzuki et al.   INTERNATIONAL IMMUNOLOGY

Endothelial Fli1 Deficiency Impairs Vascular Homeostasis

(2010) Yoshihide Asano et al.   AMERICAN JOURNAL OF PATHOLOGY

The impact of Fli1 deficiency on the pathogenesis of systemic sclerosis

(2010) Yoshihide Asano et al.   JOURNAL OF DERMATOLOGICAL SCIENCE

Future treatments in systemic sclerosis

(2010) Yoshihide ASANO   JOURNAL OF DERMATOLOGY

Epithelial Cells Promote Fibroblast Activation via IL-1α in Systemic Sclerosis

(2010) Nima Aden et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

CD19 Regulates Skin and Lung Fibrosis via Toll-Like Receptor Signaling in a Model of Bleomycin-Induced Scleroderma

(2008) Ayumi Yoshizaki et al.   AMERICAN JOURNAL OF PATHOLOGY

Sclerosing skin disorders in association with multiple sclerosis. Coincidence, underlying autoimmune pathology or interferon induced?

(2008) T Hugle et al.   ANNALS OF THE RHEUMATIC DISEASES

Combined analysis of monocyte and lymphocyte messenger RNA expression with serum protein profiles in patients with scleroderma

(2008) Hangjun Duan et al.   ARTHRITIS AND RHEUMATISM

PU.1 and bacterial metabolites regulate the human gene CAMP encoding antimicrobial peptide LL-37 in colon epithelial cells

(2008) Stefan Termén et al.   MOLECULAR IMMUNOLOGY

Complex regulation of human cathelicidin gene expression: Novel splice variants and 5′UTR negative regulatory element

(2007) Houda Zghal Elloumi et al.   MOLECULAR IMMUNOLOGY